rs267608339

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 3P and 12B. PM1PM4_SupportingBP6_Very_StrongBS2

The NM_001110792.2(MECP2):​c.1197_1199delCCC​(p.Pro400del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000128 in 705,455 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000094 ( 0 hom., 0 hem., cov: 20)
Exomes 𝑓: 0.000010 ( 0 hom. 3 hem. )

Consequence

MECP2
NM_001110792.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3O:1

Conservation

PhyloP100: 3.20

Publications

9 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

PM1
In a hotspot region, there are 10 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 21 benign, 17 uncertain in NM_001110792.2
PM4
Nonframeshift variant in NON repetitive region in NM_001110792.2. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant X-154030664-TGGG-T is Benign according to our data. Variant chrX-154030664-TGGG-T is described in ClinVar as Likely_benign. ClinVar VariationId is 143389.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 7 XL,Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.1197_1199delCCCp.Pro400del
disruptive_inframe_deletion
Exon 3 of 3NP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.1161_1163delCCCp.Pro388del
disruptive_inframe_deletion
Exon 4 of 4NP_004983.1D3YJ43
MECP2
NM_001316337.2
c.882_884delCCCp.Pro295del
disruptive_inframe_deletion
Exon 5 of 5NP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.1197_1199delCCCp.Pro400del
disruptive_inframe_deletion
Exon 3 of 3ENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.1161_1163delCCCp.Pro388del
disruptive_inframe_deletion
Exon 4 of 4ENSP00000301948.6P51608-1
MECP2
ENST00000630151.3
TSL:5
c.1161_1163delCCCp.Pro388del
disruptive_inframe_deletion
Exon 4 of 4ENSP00000486089.2P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000935
AC:
2
AN:
21381
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000178
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000150
AC:
2
AN:
133195
AF XY:
0.0000206
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000106
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000154
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000102
AC:
7
AN:
684074
Hom.:
0
AF XY:
0.0000148
AC XY:
3
AN XY:
202488
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
16441
American (AMR)
AF:
0.00
AC:
0
AN:
16924
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8553
East Asian (EAS)
AF:
0.000202
AC:
2
AN:
9912
South Asian (SAS)
AF:
0.00
AC:
0
AN:
26843
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
13873
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1973
European-Non Finnish (NFE)
AF:
0.00000884
AC:
5
AN:
565388
Other (OTH)
AF:
0.00
AC:
0
AN:
24167
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.638
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000935
AC:
2
AN:
21381
Hom.:
0
Cov.:
20
AF XY:
0.00
AC XY:
0
AN XY:
5863
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
5169
American (AMR)
AF:
0.00
AC:
0
AN:
1840
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
599
East Asian (EAS)
AF:
0.00
AC:
0
AN:
937
South Asian (SAS)
AF:
0.00
AC:
0
AN:
478
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
663
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
66
European-Non Finnish (NFE)
AF:
0.000178
AC:
2
AN:
11244
Other (OTH)
AF:
0.00
AC:
0
AN:
253
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (2)
-
-
1
not specified (1)
-
-
1
Rett syndrome (1)
-
-
1
Severe neonatal-onset encephalopathy with microcephaly (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.2
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267608339; hg19: chrX-153296115; API